The following chart lists examples ... In addition, the American Diabetes Association’s treatment guidelines recommend GLP-1 agonists (the drug class Ozempic and Victoza belong to) as a ...

Need new glasses? Online eye exams and vision tests offer a convenient way to get a glasses prescription. Doctors explain ...

The Trump-Kennedy program to slash HHS funding threatens global health, scientific progress, and the lives of millions of ...

To automate the data collection process, a series of rules and reporting configurations were built in Epic EMR. These rules ...

We look back on the stars who died this year, including Gene Hackman, Michelle Trachtenberg, Val Kilmer, Angie Stone, David ...

Learn how environmental pollutants contribute to chronic illness and discover how the principles of environmental medicine ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

According to the researchers, the findings indicated that the two drugs may have neuroprotective effects for people without diabetes and may help slow the rate of cognitive decline in Alzheimer's ...

Patients with low skeletal muscle mass are at a higher risk of falling. Certain diabetes medications, particularly SGLT2 ...

Weight-reducing diabetes medications, specifically SGLT2 inhibitors and GLP-1 receptor agonists, may increase fall risk in type 2 diabetes patients due to potential muscle mass loss.

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...